As demonstrated in Fig. 9, MED8 showed increased expression levels, while KPNA2 and YBX1 showed dramatically decreased expression levels in the liver of mice with NAFLD. The gene discussed is YBX1; the disease is metabolic dysfunction-associated steatotic liver disease.